# Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer

> **NCT00945191** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 24 (actual)

## Conditions studied

- Ovarian Cancer Stage IIIC
- Ovarian Cancer Stage IV

## Interventions

- **DRUG:** CS-1008
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00945191
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-06
- **Primary completion:** 2011-08-23
- **Final completion:** 2011-08-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945191, "Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00945191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*